$ Value
$254K
Shares
2,333
Price
$109
Filed
Mar 2
Insider
Name
de la Faverie Stephane
Title
President and CEO
CIK
0001955038
Roles
Transaction Details
Transaction Date
2026-02-27
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
18,630
Footnotes
Payout of shares upon vesting of portion of non-annual Restricted Stock Units ("RSUs") granted February 24, 2025. | Not applicable. | Represents the withholding of shares for tax purposes. | RSUs vest and are paid out in shares of Class A Common Stock on a one-to-one basis on the applicable vesting date. RSUs generally vest in three approximately equal installments unless otherwise indicated. Upon payout, shares are withheld to cover statutory tax obligations. RSUs are accompanied by dividend equivalent rights payable in cash at the time of the payout of the related shares. | Non-annual RSUs granted February 24, 2025. Assuming continued employment, these RSUs will vest and be paid out as follows: 5,787 on February 26, 2027; and 5,787 on February 24, 2028.
Filing Info
de la Faverie Stephane's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | EL | M | — |
| 2026-02-27 | EL | F | $254K |
| 2026-02-27 | EL | M | — |
| 2025-11-03 | EL | M | — |
| 2025-11-03 | EL | F | $476K |
| 2025-11-03 | EL | M | — |
| 2025-11-03 | EL | M | — |
| 2025-11-03 | EL | M | — |
| 2025-08-28 | EL | A | — |
| 2025-08-28 | EL | A | — |
Other Insiders at EL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
LAUDER RONALD S
Chairman, Clinique Labs, LLC
|
— | — | 2026-04-08 |
| LAUDER AERIN | — | — | 2026-04-08 |
| STERNLICHT BARRY S | — | — | 2026-02-27 |
| FRIBOURG PAUL J | — | — | 2026-02-27 |
| Zinterhofer Eric Louis | — | — | 2026-02-27 |
|
de la Faverie Stephane
President and CEO
|
— | — | 2026-02-27 |
|
Shrivastava Akhil
Exec VP & CFO
|
— | — | 2026-02-27 |
|
Lammers Hendrik Rene
EVP & CR&IO
|
— | — | 2026-02-26 |